Annual Operating Profit
-$38.67 M
-$13.56 M-54.01%
31 December 2023
Summary:
Soleno Therapeutics annual operaing income is currently -$38.67 million, with the most recent change of -$13.56 million (-54.01%) on 31 December 2023. During the last 3 years, it has fallen by -$6.72 million (-21.04%). SLNO annual operating profit is now -4466.60% below its all-time high of -$846.80 thousand, reached on 31 December 2013.SLNO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$79.33 M
-$56.10 M-241.50%
30 September 2024
Summary:
Soleno Therapeutics quarterly operating income is currently -$79.33 million, with the most recent change of -$56.10 million (-241.50%) on 30 September 2024. Over the past year, it has dropped by -$69.97 million (-747.51%). SLNO quarterly operating profit is now -4317.25% below its all-time high of $1.88 million, reached on 31 March 2013.SLNO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$138.47 M
-$69.97 M-102.16%
30 September 2024
Summary:
Soleno Therapeutics TTM operating income is currently -$138.47 million, with the most recent change of -$69.97 million (-102.16%) on 30 September 2024. Over the past year, it has dropped by -$106.42 million (-332.00%). SLNO TTM operating profit is now -7460.67% below its all-time high of $1.88 million, reached on 31 March 2013.SLNO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.0% | -747.5% | -332.0% |
| 3 y3 years | -21.0% | -925.7% | -310.3% |
| 5 y5 years | -181.6% | -1199.5% | -596.7% |
SLNO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -54.0% | at low | -1199.9% | at low | -451.5% | at low |
| 5 y | 5 years | -181.6% | at low | -1199.9% | at low | -596.7% | at low |
| alltime | all time | -4466.6% | at low | -4317.3% | at low | -7460.7% | at low |
Soleno Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$79.33 M(+241.5%) | -$138.47 M(+102.2%) |
| June 2024 | - | -$23.23 M(+0.7%) | -$68.50 M(+27.9%) |
| Mar 2024 | - | -$23.07 M(+79.9%) | -$53.57 M(+38.5%) |
| Dec 2023 | -$38.67 M(+54.0%) | -$12.83 M(+37.0%) | -$38.67 M(+20.6%) |
| Sept 2023 | - | -$9.36 M(+12.6%) | -$32.05 M(+11.3%) |
| June 2023 | - | -$8.31 M(+1.7%) | -$28.80 M(+8.1%) |
| Mar 2023 | - | -$8.17 M(+31.5%) | -$26.65 M(+6.1%) |
| Dec 2022 | -$25.11 M(-22.2%) | -$6.21 M(+1.8%) | -$25.11 M(-0.5%) |
| Sept 2022 | - | -$6.10 M(-1.0%) | -$25.23 M(-6.1%) |
| June 2022 | - | -$6.16 M(-7.1%) | -$26.86 M(-6.6%) |
| Mar 2022 | - | -$6.63 M(+4.8%) | -$28.75 M(-10.9%) |
| Dec 2021 | -$32.26 M(+1.0%) | -$6.33 M(-18.2%) | -$32.26 M(-4.4%) |
| Sept 2021 | - | -$7.74 M(-3.9%) | -$33.75 M(+2.0%) |
| June 2021 | - | -$8.05 M(-20.6%) | -$33.09 M(-0.9%) |
| Mar 2021 | - | -$10.14 M(+29.8%) | -$33.39 M(+4.5%) |
| Dec 2020 | -$31.95 M(+37.7%) | -$7.82 M(+10.4%) | -$31.95 M(+3.0%) |
| Sept 2020 | - | -$7.08 M(-15.2%) | -$31.01 M(+3.3%) |
| June 2020 | - | -$8.35 M(-4.0%) | -$30.03 M(+10.7%) |
| Mar 2020 | - | -$8.70 M(+26.4%) | -$27.12 M(+16.9%) |
| Dec 2019 | -$23.20 M(+68.9%) | -$6.88 M(+12.7%) | -$23.20 M(+16.7%) |
| Sept 2019 | - | -$6.11 M(+12.2%) | -$19.87 M(+14.1%) |
| June 2019 | - | -$5.44 M(+14.0%) | -$17.42 M(+12.7%) |
| Mar 2019 | - | -$4.77 M(+34.2%) | -$15.46 M(+12.6%) |
| Dec 2018 | -$13.73 M | -$3.56 M(-2.5%) | -$13.73 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$3.65 M(+4.9%) | -$12.88 M(+8.6%) |
| June 2018 | - | -$3.48 M(+14.2%) | -$11.87 M(+4.5%) |
| Mar 2018 | - | -$3.05 M(+12.6%) | -$11.35 M(+17.3%) |
| Dec 2017 | -$9.68 M(+16.3%) | -$2.71 M(+2.9%) | -$9.68 M(+9.9%) |
| Sept 2017 | - | -$2.63 M(-11.4%) | -$8.81 M(+8.1%) |
| June 2017 | - | -$2.97 M(+116.2%) | -$8.14 M(+9.0%) |
| Mar 2017 | - | -$1.37 M(-25.1%) | -$7.47 M(-27.9%) |
| Dec 2016 | -$8.32 M(-31.5%) | -$1.83 M(-6.9%) | -$10.36 M(-13.9%) |
| Sept 2016 | - | -$1.97 M(-14.2%) | -$12.03 M(-9.2%) |
| June 2016 | - | -$2.29 M(-46.2%) | -$13.25 M(-5.4%) |
| Mar 2016 | - | -$4.26 M(+21.6%) | -$14.00 M(+15.1%) |
| Dec 2015 | -$12.16 M(+135.7%) | -$3.51 M(+10.2%) | -$12.16 M(+15.8%) |
| Sept 2015 | - | -$3.18 M(+4.6%) | -$10.50 M(+21.5%) |
| June 2015 | - | -$3.04 M(+25.5%) | -$8.64 M(+25.2%) |
| Mar 2015 | - | -$2.43 M(+31.4%) | -$6.90 M(+33.8%) |
| Dec 2014 | -$5.16 M(+509.3%) | -$1.85 M(+39.5%) | -$5.16 M(+33.2%) |
| Sept 2014 | - | -$1.32 M(+1.2%) | -$3.87 M(+9.3%) |
| June 2014 | - | -$1.31 M(+91.1%) | -$3.54 M(+3.8%) |
| Mar 2014 | - | -$684.00 K(+22.2%) | -$3.41 M(+302.6%) |
| Dec 2013 | -$846.80 K(-76.5%) | -$559.80 K(-43.6%) | -$847.60 K(+194.5%) |
| Sept 2013 | - | -$993.00 K(-15.6%) | -$287.80 K(-140.8%) |
| June 2013 | - | -$1.18 M(-162.5%) | $705.20 K(-62.5%) |
| Mar 2013 | - | $1.88 M | $1.88 M |
| Dec 2012 | -$3.60 M | - | - |
FAQ
- What is Soleno Therapeutics annual operaing income?
- What is the all time high annual operating profit for Soleno Therapeutics?
- What is Soleno Therapeutics annual operating profit year-on-year change?
- What is Soleno Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly operating profit year-on-year change?
- What is Soleno Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Soleno Therapeutics?
- What is Soleno Therapeutics TTM operating profit year-on-year change?
What is Soleno Therapeutics annual operaing income?
The current annual operating profit of SLNO is -$38.67 M
What is the all time high annual operating profit for Soleno Therapeutics?
Soleno Therapeutics all-time high annual operaing income is -$846.80 K
What is Soleno Therapeutics annual operating profit year-on-year change?
Over the past year, SLNO annual operaing income has changed by -$13.56 M (-54.01%)
What is Soleno Therapeutics quarterly operating income?
The current quarterly operating profit of SLNO is -$79.33 M
What is the all time high quarterly operating profit for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly operating income is $1.88 M
What is Soleno Therapeutics quarterly operating profit year-on-year change?
Over the past year, SLNO quarterly operating income has changed by -$69.97 M (-747.51%)
What is Soleno Therapeutics TTM operating income?
The current TTM operating profit of SLNO is -$138.47 M
What is the all time high TTM operating profit for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM operating income is $1.88 M
What is Soleno Therapeutics TTM operating profit year-on-year change?
Over the past year, SLNO TTM operating income has changed by -$106.42 M (-332.00%)